  | |||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
| Journal Home | |
| Current Issue | |
| AOP | |
| Archive | |
| |
| |
THIS ARTICLE  | |
| |
| Download PDF | |
| References | |
| |
| |
| |
| Export citation | |
| Export references | |
| |
| |
| |
| Send to a friend | |
| |
| |
| |
| More articles like this | |
| |
| |
| |
| Table of Contents | |
| < Previous | | |
| |
| Employment |
 |
| Nature 369, 259 - 260 (19 May 1994); doi:10.1038/369259a0 |
|
Australian pharmaceutical industry observed
Jeremy Wurm
Senior Consultant with SACS Consulting Group, which is a member of Global Partners, the worldwide executive search network, specializing in Healthcare and Biosciences. SACS Consulting Group is based at 525 Collins Street, Melbourne, Vic 3000, with offices throughout Australia.
Multinationals are investing increasingly in local operations, with indigenous rather than expatriate managements. Scientific jobs are mainly filled by Australian graduates, many with overseas experience.
| 1. | Australian Pharmaceutical Manufacturers Association — Annual Report 1992, 1993 (APMA Inc., Sydney). |
| 2. | Scrip Review (APJB, London, 1993). |
| 3. | Australian and New Zealand Biotechnology Directory 1993 (Australian Biotechnology Association Melbourne, 1993). |
© 1994 Nature Publishing Group
Privacy Policy
